Skip to main content

Currently Skimming:

8 Improving the Role of Extramural Research Networks
Pages 87-98

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 87...
... CONVERGENCE OF MULTIPLE TYPES OF DISASTER RESEARCH Lori Peek, codirector of the Center for Disaster and Risk Analysis at Colorado State University, stated that social science disaster research likely emerged in the 1920s. The first known empirical study was a doctoral dissertation by Columbia University student Samuel Henry Prince, on the 1917 explosion of a ship in Halifax, Nova Scotia, Canada.
From page 88...
... The social science disaster research community has been focused on applied concerns and policy outcomes, Peek said. The theoretical base that is available is predominately grounded in sociology, with a focus on collective behavior and organizational response, and on demographic disparities and social vulnerability.
From page 89...
... The long-term vision is to produce the Katrina Bookshelf, including books on each of the independently funded projects together in an edited collection. Peek noted that the first book on population displacement after Hurricane Katrina has been released, three more are in press (children in Katrina, cultural trauma, environmental and community impacts)
From page 90...
... Machlis explained that the SSG drew some of its organizational principles from the research and development division of the World War II intelligence agency, the Office of Strategic Services. Those principles include focus on the mission, not the process; build operational teams based on expertise, not representation, and on skill, not rank; and have direct access to leaders and decision makers.
From page 91...
... Communication during crisis requires extraordinary clarity and concise explanation of the findings, uncertainties, and implications. This is much more im portant than the literature review, background, or methods.
From page 92...
... , both prespecified quantities purchased by the SNS as well as product for surge capacity and stock rotation to maintain maximum shelf life. He reminded participants that under the Animal Rule, FDA can approve a drug or biologic product based on substantial evidence of efficacy from studies in animals when efficacy studies in humans are not ethical or feasible.3 Seligman noted that companies have a lot of information about their products that may not be in the public domain, for example, analytics particular to measuring levels of the product; additional data on product parameters (e.g., pharmacokinetics, pharmacodynamics, genetic testing/susceptibility, biomarkers)
From page 93...
... Center in Environmental Toxicology, shared several examples of UTMB's evolving involvement in research efforts in the field in direct response to disasters. The research efforts of the Community Outreach and Education Core after Hurricanes Isaac, Katrina, and Rita started simply, she said, by contacting Red Cross and community shelters to compile lists of supplies that people needed (e.g., water, mosquito repellant, adhesive bandages, antibiotics)
From page 94...
... . The mission of the consortium was to explore the health impacts and the community resiliency related to the Deepwater Horizon disaster by fostering collaborative interactions among multidisciplinary, multi-institutional, basic, and clinical investigators, supported by active involvement of community partners.
From page 95...
... CHALLENGES AND OPPORTUNITIES In summarizing the panel discussions, Abramson said that a framework for an extramural research community collaborative could include multidisciplinary strategic science teams, consortia, suppliers, and intra- and interdisciplinary research networks (see Box 8-1)
From page 96...
... SOURCE: Plenary session summary of breakout panel discussion as reported by panel facilitator David Abramson. Seligman raised a concern that it is not clear what agency or group a pharmaceutical company could engage to ensure that adequate information on benefit and safety is going to be collected when the company's product is used in a disaster response.
From page 97...
... Irwin Redlener, director of the National Center for Disaster Preparedness at Columbia University, said there is no public health infrastructure in the United States that has an authoritative overview of what the country's priorities are relative to nearly every aspect of preparedness, including how to ensure the collection of data on the use of pharmaceutical products in a crisis. There is no infrastructure that allows the government to answer a broad, important public health question simply, clearly, definitively, and quickly.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.